{
 "PrintNo":"A1793","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-01-11T14:28:59.064195Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2021-01-11","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO INSURANCE","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":539,"Name":"J. Gary Pretlow","Short":"PRETLOW"}],
 "Title":"Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing for use in tissue typing for bone marrow testing",
 "Summary":"Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens, for utilization in tissue typing for bone marrow testing.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to requiring policies and contracts of insurance providing hospital, surgical, or medical care coverage to include coverage for human leukocyte antigen testing",
 "PreviousVersions":["A4084-2007","A4988-2009","A6459-2011","A3031-2013","A1540-2015","A1769-2017","A3694-2019"]
}